Skip to main content

Abstract

The SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome describes an association between skeletal disorders consisting of bone lesions and arthritis and various dermatologic conditions; the most frequent of these are palmoplantar pustolosis and severe acne. The acronym SAPHO was firstly proposed by Chamot and co-workers [1]. Although typical cases have been described in several countries beginning from 1961, under more than 40 different acronyms and denominations including acne induced arthritis, arthro-osteitis associated with severe acne, and recurrent multifocal osteomyelitis [2–4]. Diagnostic criteria proposed by the French authors include (1) osteoarticular manifestations of palmoplantar pustolosis, severe acne (conglobata or fulminans), or hidradenitis suppurativa; (2) hyperostosis of anterior chest wall, spine, pelvis, or limb, with or without dermatosis; or (3) chronic recurrent multifocal osteomyelitis with or without dermatosis [2, 5].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 239.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chamot AM, Benhamou CL, Kahn MF, et al. Le Syndrome Acne Pustolose Hyperostose Ostéite (SAPHO). Resultats d’une enquete nationale. 85 observations. Rev Rhum Mal Osteoartic. 1987;54:187–96.

    CAS  PubMed  Google Scholar 

  2. Benhamou CL, Chamot AM, Kahn MF. Synovitis-acne-pustolosis hyperostosis-osteomyeltis syndrome (SAPHO): a new syndrome among the spondyloarthropathies? Clin Exp Rheumatol. 1988;6:109–12.

    CAS  PubMed  Google Scholar 

  3. Kahn MF. Psoriatic arthritis and synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome. Curr Opin Rheumatol. 1993;5:378–84.

    Article  Google Scholar 

  4. Khan MF, Chamot AM. SAPHO syndrome. Rheum Dis Clin North Am. 1992;18:225–46.

    Google Scholar 

  5. Kahn MF, Kahn MA. The SAPHO syndrome. Baillere’s Clin Rheumatol. 1994;8:333–62.

    Article  CAS  Google Scholar 

  6. Sonozaki H, Kawashima M, Hongo O, et al. Incidence of arthro-osteitis in patients with pustolosis palmaris and plantaris. Ann Rheum Dis. 1981;40:554–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Sonozaki H, Mitsui H, Miyanaga Y, et al. Clinical features of 53 cases with pustolotic arthroosteitis. Ann Rheum Dis. 1981;40:547–53.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Hayem G, Bouchaud-Chabot A, Benaali K, et al. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum. 1999;29:159–71.

    Article  CAS  PubMed  Google Scholar 

  9. Maugars Y, Berthelot JM, Ducloux JM, et al. SAPHO syndrome: a follow-up study of 19 cases with special emphasis on enthesis involvement. J Rheumatol. 1995;22:2135–41.

    CAS  PubMed  Google Scholar 

  10. Reith JD, Bauer TW, Schils JP. Osseus manifestations of SAPHO (synovitis, acne, pustolosis, hyperostosis, osteitis) syndrome. Am J Surg Pathol. 1996;20:1368–77.

    Article  CAS  PubMed  Google Scholar 

  11. Schilling F, Kessler S. The SAPHO syndrome – Clinical and radiological differentiation and classification on the basis of 86 cases. Z Rheumatol. 2000;59:1–28.

    Article  CAS  PubMed  Google Scholar 

  12. Toussirot E, Dupond JL, Wending D. Spondylodiscitis in SAPHO syndrome: a series of eight cases. Ann Rheum Dis. 1997;56:52–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Trotta F, La Corte R, Bajocchi G, et al. Hyperostosis and multifocal osteitis: a purely rheumatological subset of SAPHO syndrome. Clin Exp Rheumatol. 1990;8:401–4.

    CAS  PubMed  Google Scholar 

  14. Steinhoff JP, Cilursu A, Falasca GF, et al. A study of musculoskeletal manifestations in 12 patients with SAPHO syndrome. J Clin Rheumatol. 2002;8:13–22.

    Article  PubMed  Google Scholar 

  15. Van Doorum S, Barraclough D, McColl G, et al. SAPHO: rare or just nor recognized? Semin Arthritis Rheum. 2000;30:70–7.

    Article  Google Scholar 

  16. Amor B, Dougados M, Mijiyama M. Critères de classification des spondyl-arthropathies. Rev Rhum Mal Osteoartic. 1990;57:85–9.

    CAS  PubMed  Google Scholar 

  17. Dougados M, Van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991;34:1218–27.

    Article  CAS  PubMed  Google Scholar 

  18. Goupille P, Valat JP. SAPHO syndrome and spondyloarthropathy. J Rheumatol. 1996;23:1667–8.

    Google Scholar 

  19. Edlund E, Johnsson U, Lidgren L, et al. Palmoplantar pustolosis and sternocostoclavicular arthro-osteitis. Ann Rheum Dis. 1988;47:809–15.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Wagner AD, Mai U, Hammer M, et al. Long term antibiotic therapy successful in patients with SAPHO syndrome [abstract]. Arthritis Rheum. 1997;40 Suppl 9:S62.

    Google Scholar 

  21. Kirchhoff T, Merkesdal T, Rosenthal H, et al. Diagnostic management of patients with SAPHO syndrome: use of MR imaging to guide bone biopsy at CT for microbiological and histological work-up. Eur Radiol. 2003;13:2304–8.

    Article  PubMed  Google Scholar 

  22. Colina M, Lo Monaco A, Khodeir M, Trotta F. Propionibacterium acnes and SAPHO syndrome: a case report and literature review. Clin Exp Rheumatol. 2007;25:457–60.

    CAS  PubMed  Google Scholar 

  23. Kahn MF, Bouvier MD, Palazzo E, et al. Sterno-clavicular pustolotic osteitis (SAPHO): 20 year interval between skin and bone lesions. J Rheumatol. 1991;18:1104–8.

    CAS  PubMed  Google Scholar 

  24. Touma Z, Arayssi T. Long-delayed onset of chest wall pain defining a patient with SAPHO syndrome. J Clin Rheumatol. 2007;13:338–40.

    Article  PubMed  Google Scholar 

  25. Ballara SC, Siraj QH, Maini RN, et al. Sustained response to doxycycline therapy in two patients with SAPHO syndrome. Arthritis Rheum. 1999;42:819–21.

    Article  CAS  PubMed  Google Scholar 

  26. Hagemann D, Pfaffenbach B, Schmid G, Adamek RJ. Wirbelkörpederstruktionen mit massiven schmerzen durch das SAPHO-syndrom. Dtsh Med Wschr. 1999;124: 114–8.

    Article  CAS  Google Scholar 

  27. Schilling F, Wagner AD. Azithromycin: eine anti-inflammatorische wirksamkeit im einsatz bei der chronischen rekurrierenden multifokalen osteomyelitis? Eine vorläufige mitteilung. Z Rheumatol. 2000;59:352–3.

    Article  CAS  PubMed  Google Scholar 

  28. Donelly S, Doyle DV. Chronic diffuse sclerosing osteomyelitis of the humerus. Novel treatment with calcitonin. J Rheumatol. 1993;20:1073–6.

    Google Scholar 

  29. Misaki T, Dokos S, Mori E. Calcitonin treatment for intersternoclavicular ossification: clinical experience in two cases. Ann Rheum Dis. 1991;50:813–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Amital H, Applabaum H, Aamar S, et al. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford). 2004;43:658–61.

    Article  CAS  Google Scholar 

  31. Kerrison C, Davidson JE, Clearly AG, et al. Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology (Oxford). 2004;43:1246–51.

    Article  CAS  Google Scholar 

  32. Kopterides P, Pikazis D, Koufos C. Successful treatment of SAPHO syndrome with zoledronic acid. Arthritis Rheum. 2004;50:2970–3.

    Article  PubMed  Google Scholar 

  33. Solau-Gervais E, Soubrier E, Gerot I, et al. The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome. Rheumatology (Oxford). 2006;45:339–42.

    Article  CAS  Google Scholar 

  34. Pennanen N, Lapinjoki S, Urtti A, et al. Effect of liposomal and free bisphosphonates on the IL-1β, IL-6 and TNF-α secretion from RAW 264 cells in vitro. Pharm Res. 1995;12:916–22.

    Article  CAS  PubMed  Google Scholar 

  35. Braun J, Barakliakos X, Brandt J, et al. Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides. Scand J Rheumatol. 2005;34: 178–90.

    Article  CAS  PubMed  Google Scholar 

  36. Olivieri I, Padula A, Ciancio G, et al. Successful treatment of SAPHO syndrome with infliximab: report of two cases. Ann Rheum Dis. 2002;61:375–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Olivieri I, Padula A, Ciancio G, et al. Persistent efficacy of tumor necrosis factor alpha blockage therapy in SAPHO syndrome: comment on the artiche by Wagner et al. Arthritis Rheum. 2003;48:1467.

    Article  PubMed  Google Scholar 

  38. Wagner AD, Andresen J, Jedro MC, et al. Sustained response to tumor necrosis factor α-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum. 2002;46:1965–8.

    Article  PubMed  Google Scholar 

  39. Iqbal M, Kolodney MS. Acne fulminans with synovitis-acne-pustolosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab. J Am Acad Dermatol. 2005;52(5 suppl 1):S118–20.

    Article  PubMed  Google Scholar 

  40. Massara A, Cavazzini PL, Trotta F. In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology (Oxford). 2006;45:730–3.

    Article  CAS  Google Scholar 

  41. Deutshmann A, Mache CJ, Bodo K, et al. Successful treatment of chronic recurrent multifocal osteomyelitis with tumor necrosis factor-alpha blockage. Pediatrics. 2005;116:1231–3.

    Article  Google Scholar 

  42. Carpenter E, Jackson MA, Friesen CA, et al. Crohn’s-associated chronic recurrent multifocal osteomyelitis responsive to infliximab. J Pediatr. 2004;144:541–4.

    Article  PubMed  Google Scholar 

  43. Moll C, Hernández MV, Cañete JD, et al. Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature. Semin Arthritis Rheum. 2008;37(5): 299–306.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ignazio Olivieri .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Olivieri, I., Giasi, V., D’Angelo, S., Palazzi, C., Padula, A. (2014). The SAPHO Syndrome. In: Zouboulis, C., Katsambas, A., Kligman, A. (eds) Pathogenesis and Treatment of Acne and Rosacea. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69375-8_77

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69375-8_77

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69374-1

  • Online ISBN: 978-3-540-69375-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics